Ophthotech reported $-30143000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Alimera Sciences ALIM:US $ 8.2M 11.85M
Applied Genetic Technologies AGTC:US $ -14.8M 0.62M
Insmed INSM:US $ -116699000 25.3M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Novartis NOVN:VX SF 4424M 620M
Ophthotech OPHT:US $ -30.14M 4.71M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sanofi SAN:FP € 2180M 376M